NHS could offer this simple DNA test to predict drug reactions and save thousands of lives
A landmark study looking at all adverse drug reactions ever recorded in Britain since 1964 reveals just three genes could be ...
Disgraced school staff shamed after abuse of pupils
Last year a undercover BBC Panorama investigation exposed a raft of shocking incidents at the Life Wirral school on Victoria ...
Targeted Oncology2d
Analyzing Ide-cel’s Trade-offs of Efficacy and Toxicity in Myeloma
During a live event, Patrick Moore, MD, discussed the superior efficacy with ide-cel vs standard care in relapsed/refractory ...
Call The Midwife gets major filming update amid fears BBC period drama could be rested after 13 years
CALL The Midwife’s next series is in sight with filming officially confirmed amid fears for its future. The beloved BBC period show – which is the broadcaster’s most-watched ...
DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance | DelveInsight
DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...
Applied Clinical Trials Online9d
Pregnant Women: An Underrepresented Group in Clinical Trials
Recent research is showing medical treatment for pregnant women often relies on clinical data from non-pregnant female ...
Born with phocomelia, Deb Gray rode motorbikes and travelled the world
Deb Gray was born with malformed legs and no arms. From hanging out with rock stars and road-tripping across America to ...
Cancer Therapy Advisor2d
Women in Medicine: A List of Pioneers
Historically, women have faced barriers to entering the field of medicine, being relegated to roles as caregivers rather than recognized as physicians and surgeons. Before 1847, US medical schools ...
Combatting the measles threat means examining the reasons for declining vaccination rates
At a time when Canadians are bonding together to fight the tariff threat from the U.S., it would be wonderful if we could ...
DelveInsight Business Research, LLP: DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance | DelveInsight
DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory ...